ÂÜÀòÂÒÂ×

Bruce Ruggeri is currently the Vice President of Pharmacology at Modifi Bio. Prior to this role, Bruce held positions such as Vice President and Head of Biology at Prelude Therapeutics Incorporated, Chief Scientific Officer at Champions Oncology, Inc., and various senior leadership roles at companies like Incyte, Teva Pharmaceuticals, and Cephalon. Bruce also has experience as an Associate Professor at Allegheny University of the Health Sciences. Bruce holds a PhD in Biochemistry from the University of Pennsylvania, an M.S. in Food Science and Nutritional Biochemistry from the University of Delaware, and a B.S. in Biology from LaSalle University.